GD2-Targeted Immunotherapy of Neuroblastoma
Jung-Tung Hung et al, 2019, Neuroblastoma CrossRef
Alterations of Glycosphingolipids in Embryonic Stem Cell Differentiation and Development of Glycan-Targeting Cancer Immunotherapy
Alice L. Yu et al, 2016, Stem Cells and Development CrossRef
Tumor-Associated Glycans and Immune Surveillance
Behjatolah Monzavi-Karbassi et al, 2013, Vaccines CrossRef
Targeting Glycans for Immunotherapy of Human Cancers
Jung-Tung Hung et al, 2016, Glycosignals in Cancer: Mechanisms of Malignant Phenotypes CrossRef
Moving a Carbohydrate Mimetic Peptide into the clinic
Issam Makhoul et al, 2015, Human Vaccines & Immunotherapeutics CrossRef
Antibodies: At The Nexus of Antigens and Cancer Vaccines
Zenon Steplewski et al, 2015, Journal of Infectious Diseases CrossRef
Expression of CXC chemokine receptor-4 and forkhead box 3 in neuroblastoma cells and response to chemotherapy
JING SUN et al, 2014, Oncology Letters CrossRef
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
Xu Yang et al, 2022, Current Pharmacology Reports CrossRef
The cancer glycocode as a family of diagnostic biomarkers, exemplified by tumor-associated gangliosides
Ali Nejatie et al, 2023, Frontiers in Oncology CrossRef
The Extracellular Matrix and Neuroblastoma Cell Communication—A Complex Interplay and Its Therapeutic Implications
Irena Horwacik, 2022, Cells CrossRef
Targeting glycosphingolipids for cancer immunotherapy
John Yu et al, 2020, FEBS Letters CrossRef
Mechanisms, Characteristics, and Treatment of Neuropathic Pain and Peripheral Neuropathy Associated with Dinutuximab in Neuroblastoma Patients
Stefano Mastrangelo et al, 2021, International Journal of Molecular Sciences CrossRef
Engineering anti‐GD2 monoclonal antibodies for cancer immunotherapy
Mahiuddin Ahmed et al, 2014, FEBS Letters CrossRef
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells
Stanley Ly et al, 2021, Journal for ImmunoTherapy of Cancer CrossRef